Skip to main content
رجوع
Watch Compare

Regenerative Medical Technology Group Inc.

جودة البيانات: 100%
RMTG
OTC Retail Trade Miscellaneous Retail
KWD 0.03
KWD 0.00 (0.00%)
القيمة السوقية: 328,474.0
السعر
KWD 0.03
القيمة السوقية
328,474.0
نطاق اليوم
—
نطاق 52 أسبوعًا
—
حجم التداول
—
فتح —
متوسط 50 يوم / 200 يوم
—
متوسط 50 يوم / 200 يوم
—

Quick Summary

النقاط الرئيسية

Revenue grew 193.86% annually over 5 years — strong growth
Negative free cash flow of -531,399.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 123.42%
Capital efficient — spends only 7.29% of revenue on capex

النمو

Revenue Growth (5Y)
193.86%
أعلى من متوسط القطاع (3.15%)
Revenue (1Y)70.44%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-131.85%
Op. Margin-7.96%

الأمان

Debt / Equity
N/A
Current Ratio0.09
Interest Coverage-0.04

التقييم

PE (TTM)
-0.04
أعلى من متوسط القطاع (-1.06)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Retail Trade (166 نظير)
المقياس السهم وسيط القطاع
P/E 0.0 -1.1
P/B — 1.1
ROE % — -11.4
Net Margin % -131.9 -6.2
Rev Growth 5Y % 193.9 3.1
D/E — 0.5

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

لا تتوفر تقديرات مستقبلية

All Fundamental Metrics
Growth
Revenue Growth (1Y) 70.44% Revenue Growth (3Y) 63.84%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 193.86% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 6.03 M Net Income (TTM) -7.94 M
ROE N/A ROA -176.42%
Gross Margin 62.38% Operating Margin -7.96%
Net Margin -131.85% Free Cash Flow (TTM) -531,399.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.09
Interest Coverage -0.04 Asset Turnover 1.34
Working Capital -15.76 M Tangible Book Value -31.82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.04 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.05
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -161.78%
Market Cap 328,474.0 Enterprise Value -857,221.0
Per Share
EPS (Diluted TTM) -0.63 Revenue / Share 0.46
FCF / Share -0.04 OCF / Share -0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 7.29% FCF Conversion 6.69%
SBC-Adj. FCF N/A Growth Momentum -123.42

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 4.11 M 2.41 M 1.53 M 475,261.0 55,082.0
Net Income -5.56 M -9.81 M -5.51 M -12.88 M -5.90 M
EPS (Diluted) -0.44 -0.79 -0.45 — —
Gross Profit 2.82 M 1.68 M 876,967.0 145,248.0 11,128.0
Operating Income 81,181.0 — — — —
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — 8.20 M — —
D&A 220,559.0 310,102.0 152,739.0 40,858.0 800.0
Interest Expense 5.64 M — — 2.72 M 4.20 M
Income Tax -1.16 M -2.06 M -1.16 M -2.71 M —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3.82 M 2.88 M 8.08 M 9.31 M 219,734.0
Total Liabilities 31.18 M 24.67 M 20.06 M 16.06 M 6.55 M
Shareholders' Equity -27.36 M -21.80 M -11.98 M -6.76 M -6.41 M
Total Debt — — — — —
Cash & Equivalents — 530,540.0 — 2.98 M 42,534.0
Current Assets 1.25 M 574,996.0 1.69 M 3.02 M 42,534.0
Current Liabilities 28.97 M 22.25 M 12.00 M 4.22 M 914,475.0